XIVE种植体即刻植入即刻负重的临床观察

目的：评价XIVE种植体在上颌外伤前牙区即刻种植即刻负重修复的临床效果。方法：对26例前牙区单颗或多颗无法保留的外伤残根拔除后,即刻植入XIVE种植体,并即刻负重修复。种植体扭矩控制在35Ncm左右,初期稳定性良好。平均四到五个月后行永久修复。在植入后1、2、4个月对其进行临床及影像学检查。结果：32枚种植体有2枚种植体2周后出现松动,一个月后脱落,其余30枚均在预期时间内形成良好骨性愈合,最终完成修复。结论：上颌前牙区单颗或多颗牙外伤,残根无法保留者,行即刻种植即刻负重修复是可行。早期种植修复有利于减缓牙槽骨的吸收,保留软硬组织的形态,缩短疗程。     

XIVE 种植体即刻植入即刻负重的临床观察

目的:评价XIVE种植体在上颌外伤前牙区即刻种植即刻负重修复的临床效果。方法:对26例前牙区单颗或多颗无法保留的外伤残根拔除后,即刻植入XIVE种植体,并即刻负重修复。种植体扭矩控制在35Ncm左右,初期稳定性良好。平均四到五个月后行永久修复。在植入后1、2、4个月对其进行临床及影像学检查。结果:32枚种植体有2枚种植体2周后出现松动,一个月后脱落,其余30枚均在预期时间内形成良好骨性愈合,最终完成修复。结论:上颌前牙区单颗或多颗牙外伤,残根无法保留者,行即刻种植即刻负重修复是可行。早期种植修复有利于减缓牙槽骨的吸收,保留软硬组织的形态,缩短疗程。     

OSFE植骨与不植骨种植修复的临床效果对比研究

目的:比较上颌窦挤压内提升(OSFE)植骨与不植骨种植修复的临床效果。方法:选择上颌后牙区种植修复的35例患者,其剩余牙槽嵴高度(RBH)为4~8 mm,共植入43颗种植体。A组16例患者为植骨组,20个种植位点,牙槽骨可用骨高度平均(5.87±1.19)mm,植入人工骨粉后植入种植体;B组19例患者为不植骨组,23个种植位点,缺牙区牙槽骨可用骨高度平均(5.67±1.10)mm,上颌窦提升后直接植入种植体。6个月后行二期手术完成修复。采用临床检查、X线检查及视觉模拟评分法(visual analogue scale,VAS)进行效果评价。结果:两组病例的牙槽嵴高度差异比较无统计学意义。在平均约36.7个月的随访期内,A组种植体的存留率为100%(20/20),B组中有1枚种植体因咬合力过大及口腔卫生较差脱落,种植体的存留率为95.6%(22/23),两组病例的存留率比较无统计学差异。两组患者的VAS值比较亦相当。所有种植体骨结合良好,种植体周围软组织无炎症,种植义齿咀嚼功能良好。结论:在严格控制适应症、准确掌握种植技巧的前提下,RBH在4~8 mm之间的病例无需额外植入骨代替材料即可取得理想的修复效果,简化了手术的操作,减少了手术的风险和创伤,节省了手术的时间和费用,易被患者接受。     

Xive种植体周龈下可疑致病菌变化的1年观察

目的研究一年内Xive种植体周常见致病菌的变化情况,为种植体的定期维护提供理论基础。方法临床选取32名种植患者的44枚种植体,记录了修复后1个月,修复后3个月,修复后6个月,修复后12个月四个时段,入选种植牙的菌斑指数（PLI）,牙龈指数（G1）,牙龈出血指数（GBI）,探诊深度（PD）;采用产黑菌、放线菌、具核梭杆菌及厌氧菌的选择性培养基对龈下菌斑标本进行了分离培养。结果随时间延长,种植体周几种龈下菌的检出量除牯放菌外不断增加,1个月到3个月时增加的趋势最为明显,到6个月左右趋于稳定。厌氧菌总数、产黑菌、核梭菌、粘放菌的统计值在1个月和3个月、3个月和6个月比较差异有显著性,但在6个月和12个月比较差异无显著性。各临床指标和X-线指标随时问的变化差异无显著性。结论在临床工作中,应注意加强修复后3个月时种植患者的口腔维护,防止种植体周围炎的发生,提高种植成功率。     

下颌LOCATOR种植覆盖义齿咀嚼效率的比较

目的：种植支持的覆盖义齿是针对下颌骨后牙区没有足够骨量的病人的一种适当的治疗方案。LOCATOR是近年来一种新型改良的种植体附着系统。本研究在病人佩戴LOCATOR附着系统支持的下颌种植覆盖义齿后,通过比较不同种植体数量对咀嚼效率的影响,以期用最小的成本达到较好的临床效果。方法：19名下颌无牙颌患者中,10名植入2枚种植体,9名植入3枚种植体。三月后行LOCATOR附着系统支持的种植覆盖义齿修复,并计算咀嚼效率增加量。结果：通过SPSS20．0软件进行统计分析,采用95％可信区间,α=0．05,对两组覆盖义齿咀嚼效率的增加量进行t检验：P〉0．05,两组之间咀嚼效率的增加量无显著性差异。针对下颌LOCATOR种植覆盖义齿,植入两枚种植体和三枚种植体提升的咀嚼效率并无统计学差异。结论：针对LOCATOR系统支持的下颌种植覆盖义齿,两枚种植体既能有效地提高咀嚼效率。     

慢性牙周炎对牙种植修复的疗效影响

目的:分析慢性牙周对种植义齿修复疗效的影响。方法:选择2013年7月至2015年6月在宝鸡市中医医院接受牙种植修复治疗的慢性牙周炎患者52例(70枚)作为观察组及同期接受牙种植的牙周健康患者49例(69枚),作为对照组。观察分析两组患者种植修复1、3、6、12个月的边缘骨吸收量(MBL)、改良菌斑指数(m PLI)、改良龈沟出血指数(m SBI)、探测深度(PD)以及种植体龈沟液IL-1、IL-6水平的变化情况。结果:种植1年后,对照组的种植成功率为97.10%(67/69),观察组的种植成功率为91.42%(64/70),两组比较差异无统计学意义(P0.05)。种植1个月及3个月后,两组的m PLI、m SBI、PD以及MBL比较无明显差异(P0.05);种植6个月后,观察组的m SBI、PD以及MBL显著高于对照组(P0.05),m PLI仍无明显变化。此外,种植1个月、3个月时,对照组的IL-1β未检出;6个月后,观察组的IL-1β显著高于对照组(P0.05);种植3个月后,观察组的IL-6显著高于对照组(P0.05)。结论:慢性牙周炎可降低牙种植修复治疗的疗效,可能与种植体周围炎的发生有关。     

种植体稳定系数测定与种植体负重时机选择

目的:通过测量ITI和Osstem-SS种植系统的稳定系数(ISQ),评价这两种种植体的骨结合情况,为临床确定其上部结构修复时机提供依据。方法:93例牙列缺损患者共植入179颗种植体,根据患者种植区骨量情况分为两组,其中A组为种植区骨量良好,不需骨增量手术病例(62例);B组为种植区骨量不足,需进行骨增量手术病例(31例)。A组共植入125颗种植体,其中ITI种植系统64颗,OSSTEM-SS种植系统61颗;B组共植入54颗种植体,其中ITI种植系统28颗,OSSTEM-SS种植系统26颗。术后即刻及第4、6、8、12、16、24周分别测量各时期种植体稳定系数(ISQ),并同期进行临床和影像学检查。结果:A组中ITI种植系统术后8周ISQ值平均(74.17±1.85),进行负重;OSSTEM-SS种植系统术后12周ISQ值平均(72.00±2.59),进行负重。B组中ITI种植系统术后16周ISQ值平均(65.09±3.42),进行负重;OSSTEM-SS种植系统术后24周ISQ值平均(62.09±6.16),进行负重。负重后临床随访3-24个月所有病例均成功,咀嚼功能良好,患者满意。结论:种植体稳定系数(ISQ)能反应种植体骨结合情况,可以协助医生选择种植后合适的冠修复时机。     

自体颏部骨移植并种植体修复前牙槽骨缺损的应用研究

目的:评价自体颏部骨移植方法在前牙槽骨缺损植骨及种植的效果。方法:对16例前牙骨缺损的患者进行自体颏部骨移植,分别于植骨12～16周后植入种植体,共植入18枚种植体,术后16～20周完成修复治疗。结果:16例自体骨移植患者中,1例出现术后感染,经局部冲洗换药后后愈合良好,其余患者移植骨均已成活,修复后种植体至今均无脱落,局部外形良好。结论:自体颏部骨移植能有效恢复局部牙槽外形,为前牙美学修复提供良好的基础。     

即刻种植修复与延期种植修复对上颌单前牙患者牙周组织健康、美学效果以及炎症因子的影响

摘要 目的：探讨即刻种植修复与延期种植修复对上颌单前牙患者牙周组织健康、美学效果以及炎症因子的影响。方法：回顾性分析2017年3月~2018年12月期间收治的80例上颌单前牙患者的临床资料,根据种植修复方式的不同分为A组（n=40,延期种植修复）和B组（n=40,即刻种植修复）,比较两组患者植牙成功率、牙周组织健康、美学效果、炎症因子及并发症。结果：两组植牙成功率比较无差异（P>0.05）。两组修复后1个月、3个月、6个月、12个月牙周袋深度依次降低（P<0.05）;B组修复后1个月、3个月、6个月、12个月牙周袋深度均低于A组（P<0.05）。两组修复后1个月、3个月、6个月、12个月红色美学指数（PES）评分依次升高（P<0.05）;B组修复后1个月、3个月、6个月、12个月PES评分均高于A组（P<0.05）。两组修复前、修复后7 d、修复后30 d血清肿瘤坏死因子-α（TNF-α）、C反应蛋白（CRP）水平均呈升高后降低趋势,B组修复后7 d、修复后30 d血清TNF-α、CRP水平均低于A组（P<0.05）。两组均未见严重并发症发生。结论：与延期种植修复相比,即刻种植修复治疗上颌单前牙患者对其牙周组织健康改善效果更佳,且炎症反应更轻微 ,美学效果更好,疗效显著且安全性好。     

KOM一段式种植体即刻种植的动物实验研究

目的：观察KOM一段式种植体即刻种植骨愈合过程,探索即刻种植的可行性。材料与方法：将6只狗分3组分别作实验。每组2只动物行KOM一段式种植体即刻种植愈合过程观察;动物分别于术后1、2、3个月处死2只大体标本观察、X线片、光镜、扫描电镜观察;结果：KOM一段式种植体即刻种植可以达到骨怀愈合。结论：1、KOM一段式种植体的即刻种植是一种临床可行的种植方式。2、即刻中植时种植体与骨组织之间的骨间隙是否充填生物替代材料,除了考虑种植体周围骨间隙的大小,还要考虑种植体的初期稳定性。     

Osseointegrated alloplastic ear reconstruction with the implant-carrying plate system in children

Osseointegration biotechnology has revolutionized ear prosthetic retention, and the benefits of osseointegrated alloplastic ear reconstruction have been well documented. The aim of this study is to present the authors' clinical experience with the implant-carrying plate system (EPITEC System) in children. For 3.5 years, 14 microtia patients (13 boys and one girl, ages 6 to 16 years) were treated with osseointegrated prosthetic ear reconstruction. A total of 30 titanium implant posts of the system were used; one of the patients had bilateral defects. Implant posts were inserted into a three-dimensional carrier plate, which was fixed by means of screws to the mastoid. All patients were operated on using a one-stage procedure allowing 2 to 3 months for osseointegration, followed by fabrication of the ear prostheses. After follow-up, which varied from 6 to 42 months for each patient, all implants that could be monitored were found to be stable. A total of 21 implant posts remained free from potentially dangerous skin reactions. The soft tissues around five of the implant posts in three patients were hypertrophied. One patient was lost to follow-up. The results suggest that the implant-carrying plate system offers several advantages in children: (1) Location of the implants is independent of the recipient bone available; (2) no apparent submergence is evident; (3) additional anchoring is achieved by newly formed bone growing over and covering the connecting bars of the three-dimensional carrier plate, which is only 1 mm thick; and (4) osseointegration is highly successful. Because of the limited number of cases represented in this article, along with a rather limited observation period, this study is preliminary. For a final evaluation, a longer observation time is needed. Despite this, the authors believe that a one-stage procedure with the system in the mastoid process in children can be recommended.     

羟基磷灰石义眼台植入联合一期钛钉打孔术的效果研究

目的：探讨国产医用钛钉系统联合改良羟基磷灰石义眼台钛钉打孔术的手术效果。方法：选择32只健康家兔并将其分两组,在球内容摘除术后分别行单纯义眼台植入及义眼台植入联合一期钛钉打孔术,于2、4、6、12w时每组分别处死4只家兔,观察和评价家兔对钛钉的生物耐受性及HA植入物的血管化过程。以动物实验为基础,对87例患者行羟基磷灰石义眼台一期植入联合钛钉打孔术,随访12个月,观察其手术效果及与此术式相关的并发症,总结分析国产医用钛钉系统联合改良羟基磷灰石义眼台钛钉打孔术的手术效果及优点。结果：动物实验显示：一期钛钉植入术未发生钛钉移位、排斥,扫描电镜结果表明：2、4、6、12w时两组HA血管化过程无显著差异,6w时钛钉周围1mm范围内与其完全对应的环行区域内血管化程度没有显著差异。临床实验显示：改良术式与二期打孔术相比,义眼片活动度显著提高（P〈0．01）,差异有统计学意义（P〈0．05）。两组术后肉芽肿的发生率比较无统计学差异（P〉0．05）。结论：一期植入钛钉生物相容性好,改良术式临床效果佳,术后并发症少。     

Capsule injection for the prevention of contracture

From 1990 through 1999, 164 patients with prior augmentation mammaplasty underwent implant removal by the author, and 128 of the patients had the implants replaced. Of that group, 86 were noted on preoperative examination to have capsule contracture of grade III or IV. Patients with preoperative capsule contracture were offered the option of a postoperative injection of triamcinolone intended to prevent recurrent contracture. Patients who elected to have replacement with gel-filled implants were excluded. A total of 48 patients underwent injection of triamcinolone 4 to 6 weeks after surgery. Of the remaining 38 patients, 12 were not offered injection because they selected gel-filled implants and 26 declined injection. Follow-up ranged from 8 months to 10 years (mean, 46 months), and no patient was followed up for less than 8 months. Of the 48 patients who received injections, two developed recurrent contracture, one at 3 years and one at 4.5 years. Of the 26 patients who declined injection, eight had recurrent contracture (three bilateral) within 12 months. These data suggest that in this high-risk group of patients, a postoperative injection of triamcinolone can reduce the risk of recurrent contracture.     

Effectiveness of fresh frozen and cryopreserved homologue iliac crest grafts used in sinus lifting: a comparative study

In the last decade, several investigators have reported that autologous and homologous fresh frozen bones (FFB) are effective materials to restore alveolar ridges previous to insert dental implants. Recently we have used cryopreserved homologue grafts (CFFB). Here we reported a retrospective comparative study between implants inserted in FFB and CFFB evaluate their clinical outcome. Patients were treated with a split mouth scheme for bone grafting with FFB and CFFB and spiral family implants (SPI) were inserted in the same surgical time. Several variables (patient, grafts, anatomic site, implant, prosthetic restoration) were investigated. Implant’ failure and peri-implant bone resorption were considered as predictor of clinical outcome. A total of 84 SFIs were inserted in 12 patients. Implants were inserted to replace 8 incisors, 4 cuspids, 31 premolars and 41 molars. The mean follow-up was 14 months. Three out of 84 implants was lost (i.e. survival rate SVR = 96.4%) and no differences were detected among the studied variables. Similar result was obtained by analyzing the crestal bone resorption around implant’ neck (i.e. success rate). FFB and CFFB have high and comparable survival and success rate. Implants inserted with one step surgical procedure in native (i.e. not grafted) bone, FFB and CFFB have similar clinical outcome.     

Long-term comparison of a newly designed gold implant with the conventional implant in facial nerve paralysis.

Patients with complete facial nerve palsy are at risk for eye complications resulting from exposure of the cornea and loss of the blinking reflex. Failure of protection predisposes the patient to exposure keratitis, corneal abrasion and, in rare cases, blindness. The mainstays of non-surgical therapy are cumbersome, obscure vision, and are mostly helpful in patients with acute facial paralysis in whom recovery of orbicularis oculi function is expected. Methods of lid-loading using metal implants and gold eyelid weights have been reported in the literature. Between October of 1988 and March of 1995, 32 patients with lagophthalmos due to facial nerve palsy underwent a total of 34 procedures for the insertion of a gold eyelid weight. Each patient had a gold weight inserted into a small pocket between the orbicularis oculi and the tarsal plate of the upper eyelid. The gold implant is curved to fit the curvature of the eye and contains holes for fixation to the tarsus with sutures. Ingrowth of fibrous tissue through the holes may also help fix the weight in position. Between 1988 and 1991, 10 patients received 10 commercially available rectangular gold implants with 2 holes; these implants resulted in adverse effects, such as infection and exposure in up to 30 percent of the cases. Because of the high complication rate with the rectangular gold implant, the authors began using a new, elliptical gold implant with 3 holes, which is longer, thinner, wider in the center, and narrower in the peripheral portion. This new elliptical implant was used on 22 patients (24 implants) from December of 1991 through March of 1995. The mean follow-up time for the 32 patients in the study was 41.3 months (range, 6 to 63 months), 49.8 months for patients with rectangular implants and 32.8 months for patients with elliptical implants. The elliptical gold implant resulted in dynamic closure of the eyelid and in excellent protection and cosmesis. Lagophthalmos and exposure keratitis resolved, visual acuity significantly improved without complications, and most patients could dispense with eyedrops and salves. A lower eyelid supporting procedure (conchal cartilage graft) should be performed simultaneously in patients with lagophthalmos of a moderate or severe degree to achieve complete closure of the eyelid. Use of a tall pillow decreased the incidence of eyelid opening during sleep. Double eyelid fold operations'were performed on the contralateral eyelid after 6 months, resulting in a symmetrical and beautiful eyelid.     

Treatment of midfacial defects using prostheses supported by ITI dental implants

The purpose of this study was to evaluate retrospectively the use of ITI dental implants used for anchoring facial prostheses in the restorative treatment of midface defects. The authors analyzed the clinical data of 26 patients with orbital defects (n = 11), orbitonasal defects (n = 4), orbitonasomaxillary defects (n = 3), and nasal defects (n = 8). Data included age, sex, primary disease, implant position, implant length, implant failure, prosthetic attachment, radiation therapy, and peri-implant skin reactions. Follow-up was at 1, 3, 6, and 12 months and then on a yearly basis. The authors noted the status of healing and complications, if any. In total, 62 implants were placed as follows: 27 (43.5 percent) for orbital prostheses, 12 (19.4 percent) for orbitonasal prostheses, 14 (22.6 percent) for orbitonasomaxillary prostheses, and nine (14.5 percent) for nasal prostheses. Thirty-eight implants (61.3 percent) were placed in previously irradiated areas in 18 patients (69.2 percent). Mild skin reactions together with mild accumulation of sebaceous crusting around implants were recorded in 14.2 percent of the skin observations. No patient experienced severe inflammation requiring administration of systemic antibiotics or surgical revision. Implant success was 100 percent in both irradiated and nonirradiated patients. In conclusion, ITI dental implants result in a high rate of success in retaining midface prostheses and offer good stability and aesthetic satisfaction.     

慢性鼻窦炎鼻内镜术后问卷评估分析

目的：探讨问卷随访对慢性鼻．鼻窦炎、鼻息肉患者鼻内镜术后疗效的评价意义。方法：采用Lurid-Machay的病人症状评分系统及鼻腔鼻窦结局测量20条（sino．nasaloutcometest-20,SNOT．20）中文版,对127例慢性鼻-鼻窦炎、鼻息肉术前、术后3个月、术后6个月患者进行相关问卷测试,并与100名进行健康入职体检者的相关问卷结果进行比较。结果：鼻内镜术后患者的主观症状在术后3个月较术前均明显改善,并在术后6个月时全面改善,差异均有统计学意义（P〈0．05）,但部分症状与健康受访者相比仍有差异。结论：问卷随访作为术后鼻部生理功能恢复的评估手段,有助于对术后疗效进行客观的综合评价。     

The biomaterial influences the ossification after sinus floor elevation using tissue-engineered bone grafts

Sinus floor elevation is the standard procedure that allows dental implant insertion in the atrophic posterior maxilla. Instead of autogenous bone, tissue-engineered bone grafts can be used, but clear comparative clinical studies also assessing the influence of the biomaterial are missing. In six patients, tissue-engineered bone grafts were used in eight sinus floor elevations. After culturing osteoblast-like cells from biopsies of the maxilla, they were seeded on scaffolds made either from demineralised bovine bone matrix (DBBM) or from solvent-dehydrated mineralised bone (SDBB), and grafted. In all patients primary wound healing was without complications, except for one patient in the SDBB group. After 12 months, implant insertion was possible only in the SDBB group; in the DBBM group, fibrous connective tissue was found in an attempt of implant insertion. After 5 months, implant placement was performed in one patient of each group. However, the two implants inserted in the DBBM group were lost after 6 weeks. Histology of the bone cores in the DBBM group at 5 months showed lamellar bone and osteoid, and at 12 months showed fibrous connective tissue. Inflammation and some resorption of the scaffold was found 5 months after SDBB grafting, and after 12 months cancellous bone formation encapsulating SDBB remnants were observed. These preliminary data suggest that the preparation method of the bovine bone matrix, in particular the mineral content, and therefore the mechanical stability may have some influence on the generation of new bone.